FASEB Catalyst Conferences
A new program is joining the FASEB Science Research Conferences series: Catalyst Conferences. These short, virtual meetings are intended to help foster communities in emerging areas of biology.
Catalyst Conferences will allow organizers to:
- Test new topic areas for potential conferences
- Create a following for a field of research
- Make the case for support from new sponsors for an emerging topic
- Build a speaker pool for new conferences
- Gain the skills and confidence they need to become future SRC organizers
Types of Catalyst Conferences
Catalyst Conferences provide researchers an opportunity to choose between two levels of entry based on expected attendance and funds raised:
- Entry level: A half-day virtual program with four to five speakers, a minimum of 100 attendees, no fundraising goals, and no registration fees
- Advanced level: Two consecutive half-day virtual programs with a minimum of 125 attendees, a $500 fundraising goal, and a registration fee of $50 ($25 for students). If $5,000 is raised, registration is free for all participants.
Entry-level conferences will have an opportunity to move up to an advanced-level Catalyst Conference. Advanced-level conferences that meet attendance and fundraising goals will be encouraged to move to the next level of the program, a full-fledged Science Research Conference. Conferences of either level that do not meet attendance and fundraising goals will be allowed a second attempt within a 12-month period.
Learn more about organizing a Catalyst Conference in this recorded webinar. If you have questions or are ready to get started, email us.
Imaging Cells to Organisms for Basic Science and Medical Research
Date: Wed. Apr.14, 2021
Time: 9:00 AM-2:00 PM ET and 1:00-6:00 PM GMT
Organizers: Akwasi Agbleke PhD, Harvard Center for Biological Imaging, President, Sena Institute of Technology, Penyi, Ghana, Thomas Broker PhD, Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Andrew Seeber PhD, Center for Advanced Imaging at Harvard
Summary: This Catalyst conference, in collaboration with the Sena Institute of Technology African Seminar Series, will bring together academic and clinical partners across the globe. It focuses on engaging researchers from the African continent to discuss emerging technologies on biological imaging and their applications in medical research. This short conference acts as a primer for the FASEB conference “Imaging Cellular and Chromosome Dynamics Conference”, which will be hosted in Accra, Ghana in October 2022.
Agenda: Preliminary Agenda
B Cells in Injury and Regeneration
Date/Time: Apr. 21, 2021, 1:00-5:00 PM ET
Organizer: Ruxandra Sîrbulescu, PhD, Vaccine & Immunotherapy Center, Mark C. Poznansky, MD, PhD, Vaccine & Immunotherapy Center
Summary: This one-day symposium will bring together experts in B cell biology to discuss the potential of B cell application in the context of injury and tissue repair, as well as inflammatory disease. This topic, with both fundamental and clinical implications, has been the object of a number of studies over the past decade, and the mechanisms underlying this neglected potential of B cells are being increasingly elucidated. Discussions will focus on the regulatory, immunomodulatory, and pro-regenerative functions of B cells in diverse model systems, from brain injury and stroke to wound healing, to organ transplantation.
Agenda: Preliminary Agenda
Past Catalyst Conferences
Integrative Approach for Complex Diseases Prevention and Management and Beyond
Date/Time: Wed. Dec. 16, 2020, 10:00 AM-1:05 PM ET
Organizer: Kei Hang Katie Chan, PhD, MPH, Asst. Professor, City University of Hong Kong
Summary: Diseases-driven approaches, including multi-omics and molecular epidemiology, have been applied to dissect the etiological and pathophysiological mechanism of many different complex diseases, including metabolic diseases such as diabetes and cardiovascular diseases as well as cancers, and to provide insights for diseases or mortality classification and stratification. These studies have sparked important insights in the prevention and management of these diseases and beyond.
Meiotic Recombination in Plants
Date/Time: Wed. Jan. 20, 2021, 10:00 AM-3:30 PM ET
Organizer: Gaganpreet Sidhu, PhD, Associate Research Scientist, Columbia University Medical Center
Summary: Meiotic recombination plays a critical role in crop improvement as novel gene combinations are created during meiosis. This conference aims to bring together investigators studying meiotic recombination in plants with a special focus on the future of crop improvement.
Transplantation Genomics: Ethics of Research and Clinical Applications
Date/Time: Wed. Jan. 27, 2021, 1:00-5:00 PM ET
Organizer: Tamar Schiff, MD, NYU Grossman School of Medicine
Summary: Advances in genetic and genomic studies have identified an increasing number of novel biomarkers of potential use in transplant-related care. These include predictors of disease course, graft survival, response to immunosuppression, and likelihood of post-transplant disease recurrence or other complications. Future clinical applications of these genomic findings raise ever-growing considerations of the significance of genetic variants, fair access to precision medicine therapeutics, participation in research, ethical approaches to data aggregation and analysis, and social determinants of health. This conference will examine the unique ethical, legal, and social issues at the intersection of translational genomics and transplant clinical care, focusing on questions of utility, equity, privacy, consent, and adherence to best practices.
Extracellular and Organismal Proteostasis in Health and Disease
Dates/Time: Feb. 3, 2021 1:00-5:00 PM (ET) and Feb. 4, 2021 1:00-4:40 PM (ET)
Organizers: Patricija van Oosten-Hawle, PhD, University of Leeds, UK, Ruth Scherz-Shouval, PhD, Weizmann Institute of Science, Israel, and Rebecca Taylor, PhD, MRC Laboratory of Molecular Biology, UK
Summary: The proteostasis network is essential for the maintenance of cellular health and viability. Research to date has largely focused on the intracellular function of this network in health and disease. Recent advances in the field are, however, highlighting an equally important role of an extracellular proteostasis network that protects protein folding in the extracellular space and maintains inter tissue signaling in organisms with relevance for immunity, cancer, and neurodegenerative diseases. This conference aims to unite all the pioneers of the field to take the proteostasis network to new horizons beyond the boundaries of the cell.
Dormancy in Cancer
Date/Time: Wed. Feb. 10, 2021, 11:00 AM-3:30 PM ET
Organizer: Ze'ev Ronai, PhD, Chief Scientific Advisor, Professor, Cancer Center, Sanford-Burnham-Prebys, Medical Discovery Institute
Summary: Tumor dormancy is appreciated as a stage in which tumor cells stop proliferating while surviving in a quiescent state. The possible implications of tumor dormancy and tumor metastasis on one hand and stemness on the other are among the key questions we wish to address — the focus of this catalyst symposium.
In Vivo Models of Relevance to PKD Research
Sponsored by PKD Foundation
Date/Time: Wed Mar. 31, 2021, 10:15 AM-3:30 PM ET
Organizer: Stephen C. Parnell, Ph.D., University of Kansas Medical Center (On behalf of the PKD Research Resource Consortium-RRC)
Summary: The purpose of this conference is to educate new PKD investigators about mouse models available for research, to inform the PKD research community about new mouse models being developed by the PKD Research Resource Consortium, and to solicit feedback and discussion from the PKD research community regarding the production of new animal model technologies for PKD research.
Cholangiocarcinoma: Molecular Drivers, Microenvironment, and Precision Medicine
Date/Time: Wed. Apr. 7, 2021, 1:00-5:30 PM ET
Organizer: Alphonse E. Sirica, PhD, MS, Professor Emeritus, Pathology Department, Virginia Commonwealth University
Summary: Cholangiocarcinoma (CCA) is a heterogeneous class of highly aggressive and fatal primary epithelial cancers arising within the biliary tract. After hepatocellular carcinoma, CCA is the second most common primary liver cancer, accounting for approximately 10-20% of all primary hepatic malignancies. Over the last 10-20 years, intrahepatic CCA has notably become the focus of increasing concern largely due to its rising incidence and high mortality rates in various parts of the world. In the U.S., the rising incidence and mortality rates from this primary hepatobiliary cancer, particularly over the past decade or so, have coincided with a rapidly growing interest among clinicians, investigators, and patient advocates seeking greater mechanistic insights and more personalized targeted molecular and immunotherapeutic approaches for managing and/or preventing this challenging hepatobiliary cancer. We will highlight timely research findings focused on key molecular drivers, the tumor reactive stroma, and immune milieu in relation to CCA development, malignant progression, morpho-molecular heterogeneity, and therapeutic resistance, together with emerging strategies for advancing novel molecular and immunotherapies for CCA.
Catalyst Conference Policies and Code of Conduct
For the safety and enjoyment of all, FASEB has developed Catalyst Conference Policies and Code of Conduct that applies to all FASEB Catalyst Conference participants. All policies are adopted in consideration of and in the best interest of conference participants. By registering for the conference, the participant agrees to abide by all said policies. Download the Policies and Code of Conduct.